Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedPal AIFRA:Z1N Enterprise Value is €28.76 Mil as of Aug. 04, 2026. The stock has 1 warning sign investors should review.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MedPal AI's Enterprise Value is €28.76 Mil.
MedPal AI's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 was €-6.23 Mil. Therefore, MedPal AI's EV-to-EBIT ratio for today is -4.62.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, MedPal AI's Enterprise Value is €28.76 Mil.
MedPal AI's EBITDA for the trailing twelve months (TTM) ended in Feb. 2026 was €-6.16 Mil. Therefore, MedPal AI's EV-to-EBITDA ratio for today is -4.67.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, MedPal AI's Enterprise Value is €28.76 Mil.
MedPal AI's Revenue for the trailing twelve months (TTM) ended in Feb. 2026 was €1.84 Mil. Therefore, MedPal AI's EV-to-Revenue ratio for today is 15.59.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, MedPal AI's Enterprise Value is €28.76 Mil.
MedPal AI's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2026 was €-5.19 Mil. Therefore, MedPal AI's EV-to-FCF ratio for today is -5.54.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
MedPal AI's current Enterprise Value is €28.76 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. MedPal AI's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 was €-6.23 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
MedPal AI's current Enterprise Value is €28.76 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. MedPal AI's EBITDA for the trailing twelve months (TTM) ended in Feb. 2026 was €-6.16 Mil.
MedPal AI's current Enterprise Value is €28.76 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. MedPal AI's Revenue for the trailing twelve months (TTM) ended in Feb. 2026 was €1.84 Mil.
MedPal AI's current Enterprise Value is €28.76 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. MedPal AI's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2026 was €-4.95 Mil.
MedPal AI's current Enterprise Value is €28.76 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. MedPal AI's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2026 was €-5.19 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedPal AI Enterprise Value Related Terms
MedPal AI Enterprise Value Historical Data
* Premium members only.
The historical data trend for MedPal AI's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:Z1N vs VEEV, BTSG, HQY: Enterprise Value Comparison
For the Health Information Services subindustry, MedPal AI's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedPal AI Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's Enterprise Value distribution charts can be found below:
* The bar in red indicates where MedPal AI's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
MedPal AI's Enterprise Value for the fiscal year that ended in Aug. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedPal AI (FRA:Z1N) has a Enterprise Value of €28.76 Mil as of Aug. 04, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on MedPal AI and its competitors.
Is MedPal AI's Enterprise Value too high?
MedPal AI's current Enterprise Value is €28.76 Mil.
How does MedPal AI's Enterprise Value compare to VEEV and BTSG?
MedPal AI's Enterprise Value of €28.76 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on MedPal AI and its competitors. MedPal AI's current Enterprise Value is €28.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (FRA:Z1N) has a current Enterprise Value of €28.76 Mil. The current Enterprise Value is €28.76 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For MedPal AI (FRA:Z1N), the current Enterprise Value is €28.76 Mil as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Z1N has been successfully added to your 
